Found 2560 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) PHASE1 Primary trial objective in this single arm trial is to assess the safety an...
Show More Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer PHASE2 The goal of this single-arm, Phase II interventional clinical trial is to t...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer PHASE3 This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain N/A Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Show More Learn More & Join Trial
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma PHASE4 The purpose of this study is to determine whether the rituximab administrat...
Show More Location
Hospital Infanta Cristina
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC N/A To estimate parameters related to clinical outcomes in a real-world seeting...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 PHASE2 This is a single-center, prospective, single-arm, open-label phase II study...
Location
Asan Medical Center
Learn More & Join Trial
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC PHASE2 This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Show More Location
Multiple Locations
Learn More & Join Trial